VRUS – Roadmap of R7128 results in phase-1 combination study with peg-ifn and ribavirin.<pre><b> Dose HCV Trtmnt iHub <u>Cohort</u> <u>(BID)</u> <u>Genotype</u> <u> Line </u> <u>Reference</u></b> 1 500mg 1 1st <a href='read_msg.asp?message_id=28837612'>#msg-28837612</a> 2 1500mg 1 1st <a href='read_msg.asp?message_id=28837612'>#msg-28837612</a> 3 1000mg 1 1st <a href='read_msg.asp?message_id=31218459'>#msg-31218459</a> 4 1500mg 2/3 2nd <a href='read_msg.asp?message_id=31999860'>#msg-31999860</a></pre>